Zeyang Hu

Establishment of a direct quantitative method for measurement of microRNA-224 in serum by UHPLC/MS/MS.

S. Ju, Anqi Wu, Yi Li, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma.

Q. Gao, Jia Fan, Jian Zhou, 2022, Journal of hepatology.

Construction of an algorithm based on oncosis‐related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma

Hang Chen, Linwen Zhu, Q. Pan, 2022, Journal of clinical laboratory analysis.

Bioinformatics algorithm for lung adenocarcinoma based on macropinocytosis-related long noncoding RNAs as a reliable indicator for predicting survival outcomes and selecting suitable anti-tumor drugs

Linwen Zhu, Q. Pan, Shuguang Xu, 2022, Medicine.

Prognostic significance of TRIM28 expression in patients with breast carcinoma

Anqi Wu, Mingzhu Kong, Feng Wang, 2021, Open medicine.

IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis

Zeyang Hu, Da-wei Zheng, Guodong Xu, 2023, Medicine.

Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma

Weijia Ding, Anqi Wu, Yi Li, 2021, Frontiers in Pharmacology.

Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non‐small cell lung cancer cells via p53‐p21 signaling pathway

Zhen Ge, Sufang He, Hang Chen, 2022, Journal of clinical laboratory analysis.

Early outcomes of primary repair versus reconstruction for acute anterior cruciate ligament injury: A systematic review and meta-analysis

W. Shen, Zeyang Hu, Zetian Gao, 2022, Medicine.

Lysosome-related genes: A new prognostic marker for lung adenocarcinoma

Zeyang Hu, Yinyu Mu, Guodong Xu, 2023, Medicine.